-
cancer chemotherapy.
Darbepoetin is
marketed by
Amgen under the
trade name
Aranesp. The
medication was
approved in
September 2001, by the US Food and Drug...
-
cancer control in
subjects treated with
Aranesp was
significantly worse than for
those not
receiving Aranesp (p=0.01). In
response to
these advisories...
-
causing it to
remain in the body longer. This led to the
development of
Aranesp (darbepoetin alfa). In
November 1998, Immunex, a ****ure
acquisition of...
-
technology in cell culture, and
include Epogen/Procrit (epoetin alfa) and
Aranesp (darbepoetin alfa); they are used in
treating anemia resulting from chronic...
-
Epoetin beta (NeoRecormon)
Epoetin zeta (Silapo, Retacrit)
Darbepoetin alfa (
Aranesp)
Methoxy polyethylene glycol-epoetin beta (Mircera)
Recombinant erythropoietin...
- needed]
SureClick autoinjector is a
combination product for
drugs Enbrel or
Aranesp to
treat rheumatoid arthritis or anemia, respectively.[citation needed]...
-
medicines Immunology/Allergy
medicines Nephrology medicines ESPO / NESP /
Aranesp REGPARA Oncology medicines ABSTRAL GRAN /
Peglasta /
Neulasta LEUNASE Mitomycin-C...
- Drug
Marketing Act 2012
Amgen $762
million Off-label promotion,
kickbacks Aranesp False Claims Act, FDCA 2010
GlaxoSmithKline $750
million Poor manufacturing...
-
Xeloda Capecitabine 194,044 6.52%
Generic Cancer Jun-1909 Mon-20XX 94
Aranesp Darbepoetin alfa 185,225 -9.22%
Amgen Inc.
Anemia Jun-2001 Mon-20XX 95...
-
Aquasol A
Aquatag AquaTar Aquatensen Aquazide H ARA-C
Aralast Aralen Aramine Aranesp aranidipine (INN)
aranotin (INN)
araprofen (INN)
arasertaconazole (INN)...
